Russia Healthcare, Regulatory and Reimbursement Landscape – CountryFocus

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Russia”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Russian pharmaceutical market was worth $29.6B in 2012, but declined to $22.7B by 2016 due to the devaluation of the Russian ruble during the Russian Financial Crisis (2014–2017). By 2018, the economy had recovered and the pharmaceutical market had grown to $26.8B. It is forecast to reach $38.5B by 2025 at a Compound Annual Growth Rate (CAGR) of 5.3%. The Russian pharmaceutical market faces stiff competition from generic drugs. In 2018, generic drugs accounted for 61.8% of sales of the retail commercial market, while original drugs accounted for 38.2%. In 2015, the medical devices market in Russia was worth $7.07B, which increased to $7.92B in 2019. It is expected to grow at a CAGR of 4.1% from 2019 to reach $10.07B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Russia, and includes:

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

• Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Novartis, Pfizer, GlaxoSmithKline, and Pharmstandard.

• Profiles and SWOT analyses of the major players in the medical device market: Medtronic, Roche, Essilor, and Zimmer Biomet

• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure

• An overview of the opportunities for and challenges to growth in the Russian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

• Develop business strategies by understanding the trends shaping and driving Russia’s healthcare market

• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Russia’s healthcare market in the future

• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary

2.2 Key Highlights

2.3 Key Events: Russian Pharmaceutical News, 2014–2020

2.4 Key Events: Russian Pharmaceutical Market

2.5 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019–2020

2.6 Key Events: Mergers and Acquisitions

2.7 Country Profile, Russia, 2019

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Pharma 2020

3.3 Pharmaceutical Market – Exports

3.4 Pharmaceutical Market – Imports

3.5 Pharmaceutical Supply Channels, Russia

3.5 Pharmaceutical Market – Market Segments

3.6 Major Therapeutic Areas, Russia

3.7 COVID-19 Epidemiology, Russia

3.8 COVID-19 Impact and Developments in Healthcare Market, Russia

3.9 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Device Market – Major Segments

4.3 Medical Device Market – Major Players

5 Pharmaceutical and Medical Device Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Russia 2019–2020

6.2 Deal Analysis: Medical Devices, Russia 2019–2020

7 HealthTech Landscape

7.1 HealthTech Landscape

7.2 Digital Health Companies, Russia

7.3 Key HealthTech Deals, Russia

7.4 Telemedicine Regulations, Russia

7.5 HealthTech Landscape- Russia- Benefits and Risks

8 Market Access

8.1 Overview of Healthcare System, Russia

8.2 Reimbursement Process, Russia

8.3 Overview of Health Insurance, Russia

8.4 Healthcare Spending and Health Price Index, Russia

8.5 Pricing Policies, Russia

8.6 Regulatory Landscape, Russia

8.6.1 Market Authorization for Pharmaceutical Drugs, Russia

8.6.2 Regulatory Reforms, Russia

8.6.3 Market Authorization for Medical Devices, Russia

8.6.4 Licensing Process for Pharmaceutical Exports and Imports

8.6.5 Intellectual Property Rights, Patent, Russia

8.6.5 Clinical Trial Regulations, Russia

8.6.6 Pharmaceutical Clinical Trials Landscape, Russia

8.6.7 Pharmaceutical Advertising Regulations, Russia

8.6.8 Labeling Regulations, Russia

9 Country Healthcare Landscape

9.1 Healthcare Initiatives

9.2 Healthcare Facilities, Russia

9.3 Healthcare Parameters, Russia

9.4 Life Expectancy and Immunization Rate, Russia

9.5 Environmental Health, Russia

9.6 Healthcare Personnel, Russia

9.7 Disease Burden, Russia

9.8 Healthcare Expenditure

10 Trade Associations, Russia

11 Trade Fairs, Russia

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.1.4 Expert Panel

13.2 Bibliography

13.3 Contact Us

13.4 Disclaimer

List of Tables

Table 1: Major Pharmaceutical Distributors, Russia, 2018

Table 2: Sales Structure of RTU drugs by ATC groups, Russia, 2018

Table 3: COVID-19 Indicators (Number of cases), Global and Russia, 2020

Table 4: COVID-19 Clinical Trials, Russia, 2020

Table 5: COVID-19 Test Kits, Russia, 2020

Table 6: Orthopedic Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2019

Table 7: Ophthalmic Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015

Table 8: Diagnostic Imaging Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015

Table 9: Cardiovascular Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2018

Table 10: In Vitro Diagnostics Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2015

Table 11: Out-Patient Drug Reimbursement Eligibility, Russia, 2019

Table 12: Medical Equipment Risk Classification, Russia, 2019

Table 13: Patent Fees, Russia, 2019

Table 14: Trade Fairs, 2020

List of Figures

Figure 1: Pharmaceutical Market, Russia, Revenue ($B), 2012–2018

Figure 2: Medical Device Market, Russia, Revenue ($B), 2015–2020

Figure 3: Country Profile, Russia, 2019

Figure 4: Pharmaceutical Market, Russia, Revenue (RUB B and $B), 2012–2018

Figure 5: Pharmaceutical Market, Russia, Revenue Forecast (RUB B and $B), 2019–2025

Figure 6: Pharma 2020, Russia, 2020

Figure 7: Pharmaceutical Exports ($M), Russia, 2010–2019

Figure 8: Top Export Partners, Russia, 2019

Figure 9: Pharmaceutical Imports ($B), Russia, 2010–2019

Figure 10: Top Import Partners, Russia, 2019

Figure 11: OTC Market, Russia, Major Category (%), 2019

Figure 12: OTC Market, Russia, Revenue ($M), 2013–2020

Figure 13: COVID-19 (Number of cases), Russia, 2020

Figure 14: COVID-19 (Number of deaths), Russia, 2020

Figure 15: Pharmaceutical Market, Major Players, 2018

Figure 16: Medical Device Market, Russia, Revenue ($B), 2015–2020

Figure 17: Medical Device Market, Russia, Revenue Forecast ($B), 2021–2025

Figure 18: Medical Devices Market, Major Segments (%), Russia, 2019

Figure 19: Orthopedic Devices Market, Russia, Revenue ($M), 2015–2022

Figure 20: Orthopedic Devices Market, Russia, Market Share of Major Players (%), 2019

Figure 21: Ophthalmic Devices Market, Russia, Revenue ($M), 2015–2022

Figure 22: Ophthalmic Devices Market, Russia, Market Share of Major Players (%), 2015

Figure 23: Diagnostic Imaging Market, Russia, Revenue ($M), 2015–2022

Figure 24: Diagnostic Imaging Market, Russia, Market Share of Major Players (%), 2015

Figure 25: Cardiovascular Devices Market, Russia, Revenue ($M), 2015–2022

Figure 26: Cardiovascular Devices Market, Russia, Market Share of Major Players (%), 2018

Figure 27: In Vitro Diagnostics Market, Russia, Revenue ($M), 2015–2022

Figure 28: In Vitro Diagnostics Market, Russia, Market Share of Major Players (%), 2015

Figure 29: Diagnostic Market, Russia, Revenue ($M), 2015–2020

Figure 30: Diagnostic Market, Russia, Revenue ($M), 2021–2025

Figure 31: Medical Device Market, Russia, Revenue ($B) of Major Companies, 2017

Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Russia, 2019–2020

Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Russia, 2019–2020

Figure 34: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Russia, 2019–2020

Figure 35: Top Therapy Areas by Deal Value, Pharmaceutical Market, Russia, 2019–2020

Figure 36: Top Therapy Areas by Deal Number, Pharmaceutical Market, Russia, 2019–2020

Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, Russia, 2019–2020 (by value and by number)

Figure 38: Deal Value and Deal Count, Medical Devices, Russia, 2019–2020

Figure 39: Deal Value and Deal Count Quarterly, Medical Devices, Russia, 2019–2020

Figure 40: Overview of Healthcare System, Russia, 2019

Figure 41: Public Provision of Pharmaceuticals, Russia, 2019

Figure 42: Government Health Insurance (% of population), Russia, 2010–2018

Figure 43: Out-of-Pocket Expenditure ($ per capita), Russia, 2010–2017

Figure 44: Health Price Index (% change), Russia, 2011–2019

Figure 45: Drug price regulation, Russia, 2019

Figure 46: Filing Procedure for Registration of Maximum Selling Price for EDL Drugs, Russia, 2019

Figure 47: Roszdravnadzor, Organization Chart, 2020

Figure 48: Rospotrebnadzor, Organization Chart, 2020

Figure 49: Drug Approval Process, Russia, 2019

Figure 50: Drug Approval Overall Process, Russia, 2019

Figure 51: Rospatent Organization Structure, Russia, 2019

Figure 52: Patent Application Process, Russia, 2019

Figure 53: Pharmaceutical Clinical Trials Count By Trial Status, Russia, 2018–2019

Figure 54: Pharmaceutical Clinical Trials Count By Phase, Russia, 2018–2019

Figure 55: Pharmaceutical Clinical Trials Count By Therapy Area, Russia, 2018–2019

Figure 56: Top Five Pharmaceutical Clinical Trials Sponsor By Count, Russia, 2018–2019

Figure 57: Labeling information, Russia, 2018

Figure 58: Health Strategy 2020, Russia, 2020

Figure 59: Hospitals (‘000), Russia, 2011–2018

Figure 60: Outpatient Clinics (‘000), Russia, 2011–2018

Figure 61: Diagnostic Equipment (per million population), Russia, 2011–2018

Figure 62: Hospital Beds (per 1,000 population), Russia, 2011–2018

Figure 63: Hospital Beds by Specialization (%), Russia, 2018

Figure 64: Life Expectancy (in years), Russia, 2012–2018

Figure 65: Immunization Rate (%), Russia, 2010–2017

Figure 66: PM2.5 (µg per m3), Russia, 2010–2017

Figure 67: CO2 Emissions (metric tons), Russia, 2010–2018

Figure 68: Doctors (per 1,000 population), Russia, 2010–2018

Figure 69: Healthcare Personnel (per 10,000 population), Russia, 2018

Figure 70: Major Causes of Mortality (Number of persons), Russia, 2018

Figure 71: Disability-Adjusted Life Years by Major Disease (‘000), Russia, 2016

Figure 72: Healthcare Expenditure as a Percentage of GDP (%), Russia, 2010–2016

Figure 73: Health Expenditure Share (% of total health spending), Russia, 2010–2017

Figure 74: Opportunities and Challenges

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports